The Richmond company (Nasdaq: BIOA) will get a fraction of the money upfront from Novartis (NYSE: NVS) — up to $20 million, ...
Neurizon has filed an Investigational New Drug application with the US FDA for lead drug candidate NUZ-001 to treat ...
(ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce the filing of an Investigational New Drug ...
Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a ...
Limited announces that the U.S. Food and Drug Administration, FDA, has approved its suitability petition for a new animal drug ...
Executives at a local company believe they have a quicker and less expensive path to get their new drug approved.
Granules Pharmaceuticals, Inc (GPI) has received approval from the US Food & Drug Administration (USFDA) for its abbreviated ...
LONDON - A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the ...